Filing Details
- Accession Number:
- 0001209191-18-032634
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-23 16:48:14
- Reporting Period:
- 2018-05-21
- Accepted Time:
- 2018-05-23 16:48:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1207430 | H Jose Bedoya | 604 10Th Street Boulder CO 80302 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-05-21 | 11,450 | $12.40 | 30,889 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-05-21 | 11,450 | $48.17 | 19,439 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2018-05-21 | 11,450 | $0.00 | 11,450 | $12.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-11-30 | No | 4 | M | Direct |
Footnotes
- Reflects the weighted average price of 11,450 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 21, 2018 with sale prices ranging from $47.80 to $48.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The amount beneficially owned includes 8,684 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
- Fully vested.